You Get What You Pay For: Breast MRI Screening of Women With Dense Breasts Is Cost-effective.
作者信息
Kuhl Christiane K, Baltzer Pascal
机构信息
Department of Diagnostic and Interventional Radiology, RWTH Aachen University, Aachen, Germany.
Department of Biomedical Imaging and Image Guided Therapy, Allgemeines Krankenhaus Wien, Medical University, Vienna, Austria.
出版信息
J Natl Cancer Inst. 2021 Nov 2;113(11):1439-1441. doi: 10.1093/jnci/djab120.
Abstract
摘要
相似文献
1
You Get What You Pay For: Breast MRI Screening of Women With Dense Breasts Is Cost-effective.一分钱一分货：对乳腺致密的女性进行乳腺磁共振成像筛查具有成本效益。
J Natl Cancer Inst. 2021 Nov 2;113(11):1439-1441. doi: 10.1093/jnci/djab120.
2
Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program.在全国性乳腺癌筛查计划中，对乳腺致密的女性进行简化协议 MRI 筛查的成本效益。
Breast. 2022 Feb;61:58-65. doi: 10.1016/j.breast.2021.12.004. Epub 2021 Dec 10.
3
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue.磁共振成像筛查对致密型乳腺女性的成本效益分析。
J Natl Cancer Inst. 2021 Nov 2;113(11):1476-1483. doi: 10.1093/jnci/djab119.
4
Incorporating Baseline Breast Density When Screening Women at Average Risk for Breast Cancer : A Cost-Effectiveness Analysis.在对乳腺癌平均风险的女性进行筛查时纳入基线乳房密度：成本效益分析。
Ann Intern Med. 2021 May;174(5):602-612. doi: 10.7326/M20-2912. Epub 2021 Feb 9.
5
Supplemental screening using breast MRI in women with mammographically dense breasts.对乳腺钼靶检查显示乳房致密的女性，采用乳腺磁共振成像进行补充筛查。
Eur J Radiol. 2021 Mar;136:109513. doi: 10.1016/j.ejrad.2020.109513. Epub 2020 Dec 31.
6
The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.加利福尼亚州乳房密度通知立法对乳腺癌筛查的影响。
J Prim Care Community Health. 2017 Apr;8(2):55-62. doi: 10.1177/2150131916674889. Epub 2016 Oct 31.
7
Comment on: Cost-effectiveness of magnetic resonance imaging screening for women with extremely DENSE breast tissue.评论：针对乳腺组织极度致密的女性进行磁共振成像筛查的成本效益
Eur J Radiol. 2022 Apr;149:110186. doi: 10.1016/j.ejrad.2022.110186. Epub 2022 Feb 1.
8
Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare.美国医疗保健中，对伴有异质或极度致密乳腺且乳腺癌风险处于平均或中等水平的女性，进行乳腺钼靶或数字乳腺断层合成摄影术以外的补充性乳腺癌筛查方法的经济学评价。
J Med Econ. 2023 Jan-Dec;26(1):850-861. doi: 10.1080/13696998.2023.2222035.
9
Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts.乳腺筛查的非对比 MRI：致密乳腺中良恶性病变检出的初步研究。
Breast Cancer Res Treat. 2019 Oct;177(3):629-639. doi: 10.1007/s10549-019-05342-5. Epub 2019 Jul 19.
10
Reducing False-Positive Screening MRI Rates in Women with Extremely Dense Breasts.降低乳腺极度致密女性的MRI筛查假阳性率
Radiology. 2021 Nov;301(2):293-294. doi: 10.1148/radiol.2021211547. Epub 2021 Aug 17.
引用本文的文献
1
The paradox of MRI for breast cancer screening: high-risk and dense breasts-available evidence and current practice.乳腺癌筛查中MRI的悖论：高危和致密型乳腺——现有证据及当前实践
Insights Imaging. 2024 Mar 27;15(1):96. doi: 10.1186/s13244-024-01653-4.
2
Challenges of breast cancer screening.乳腺癌筛查的挑战。
Rev Bras Ginecol Obstet. 2023 Oct;45(10):622-625. doi: 10.1055/s-0043-1776716. Epub 2023 Nov 9.
3
Challenges of breast cancer screening.乳腺癌筛查的挑战。
Rev Bras Ginecol Obstet. 2023 Sep;45(9):551-554. doi: 10.1055/s-0043-1775931. Epub 2023 Oct 16.
4
Development of the prediction model based on clinical-imaging omics: molecular typing and sentinel lymph node metastasis of breast cancer.基于临床影像组学的预测模型的开发：乳腺癌的分子分型与前哨淋巴结转移
Ann Transl Med. 2022 Jul;10(13):749. doi: 10.21037/atm-22-2844.
5
The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening.致密型乳腺对乳腺癌诊断分期的影响：综述及补充筛查的选择。
Curr Oncol. 2022 May 17;29(5):3595-3636. doi: 10.3390/curroncol29050291.
6
Management of Non-Mass Enhancement at Breast Magnetic Resonance in Screening Settings Referred for Magnetic Resonance-Guided Biopsy.乳腺磁共振筛查中发现的非肿块强化灶的管理，此类患者随后接受磁共振引导下活检
Breast Cancer (Auckl). 2022 May 16;16:11782234221095897. doi: 10.1177/11782234221095897. eCollection 2022.
本文引用的文献
1
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue.磁共振成像筛查对致密型乳腺女性的成本效益分析。
J Natl Cancer Inst. 2021 Nov 2;113(11):1476-1483. doi: 10.1093/jnci/djab119.
2
Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis.全数字化乳腺摄影与屏片乳腺摄影在人群筛查中的影响：荟萃分析。
J Natl Cancer Inst. 2021 Jan 4;113(1):16-26. doi: 10.1093/jnci/djaa080.
3
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.致密型乳腺女性的补充性磁共振成像筛查。
N Engl J Med. 2019 Nov 28;381(22):2091-2102. doi: 10.1056/NEJMoa1903986.
4
Breast cancer incidence and mortality before and after implementation of the German mammography screening program.德国乳腺 X 光筛查项目实施前后的乳腺癌发病与死亡情况。
Int J Cancer. 2020 Aug 1;147(3):709-718. doi: 10.1002/ijc.32767. Epub 2019 Dec 4.
5
Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines.美国不同阶段乳腺癌发病率变化与筛查指南变更的关系
Am J Prev Med. 2019 Jan;56(1):100-108. doi: 10.1016/j.amepre.2018.08.018.
6
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey.欧洲乳腺影像学会（EUSOBI）以及来自奥地利、比利时、波斯尼亚和黑塞哥维那、保加利亚、克罗地亚、捷克共和国、丹麦、爱沙尼亚、芬兰、法国、德国、希腊、匈牙利、冰岛、爱尔兰、意大利、以色列、立陶宛、摩尔多瓦、荷兰、挪威、波兰、葡萄牙、罗马尼亚、塞尔维亚、斯洛伐克、西班牙、瑞典、瑞士和土耳其的30个国家乳腺放射学机构关于乳腺癌筛查的立场文件
Eur Radiol. 2017 Jul;27(7):2737-2743. doi: 10.1007/s00330-016-4612-z. Epub 2016 Nov 2.
7
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.美国不同乳腺癌筛查策略相关获益与危害的协同建模
Ann Intern Med. 2016 Feb 16;164(4):215-25. doi: 10.7326/M15-1536. Epub 2016 Jan 12.
8
Mammographic density phenotypes and risk of breast cancer: a meta-analysis.乳腺密度表型与乳腺癌风险：荟萃分析。
J Natl Cancer Inst. 2014 May 10;106(5):dju078. doi: 10.1093/jnci/dju078.
9
Overdiagnosis in cancer.癌症过度诊断。
J Natl Cancer Inst. 2010 May 5;102(9):605-13. doi: 10.1093/jnci/djq099. Epub 2010 Apr 22.
Zotero 插件